{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:41:59Z","timestamp":1775824919436,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jpeds.2013.12.053","type":"journal-article","created":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T15:16:38Z","timestamp":1391872598000},"page":"1195-1200","source":"Crossref","is-referenced-by-count":113,"title":["Mammalian Target of Rapamycin Inhibitors for Intractable Epilepsy and Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex"],"prefix":"10.1016","volume":"164","author":[{"given":"Michael","family":"Cardamone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mowat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean E.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2013.12.053_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","article-title":"Tuberous sclerosis complex and epilepsy: recent developments and future challenges","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpeds.2013.12.053_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jmg.28.6.395","article-title":"On the incidence of fits and mental retardation in tuberous sclerosis","volume":"28","author":"Webb","year":"1991","journal-title":"J Med Genet"},{"key":"10.1016\/j.jpeds.2013.12.053_bib3","series-title":"Tuberous sclerosis complex: Developmental perspectives in psychiatry","first-page":"29","article-title":"Natural history of cerebral tuberous sclerosis","author":"Gomez","year":"1999"},{"issue":"Suppl 10","key":"10.1016\/j.jpeds.2013.12.053_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1528-1167.2005.00353.x","article-title":"Neurocutaneous syndromes and epilepsy-issues in diagnosis and management","volume":"46","author":"Cross","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpeds.2013.12.053_bib5","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1111\/j.1528-1167.2010.02669.x","article-title":"Epilepsy surgery in tuberous sclerosis complex: emphasis on surgical candidate and neuropsychology","volume":"51","author":"Liang","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpeds.2013.12.053_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1440-1754.2011.02038.x","article-title":"An Australian tuberous sclerosis cohort: are surveillance guidelines being met?","volume":"47","author":"Chopra","year":"2011","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jpeds.2013.12.053_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF00341764","article-title":"Tuberous sclerosis: a clinicoradiological evaluation of 110 cases with particular reference to atypical presentation","volume":"28","author":"Kingsley","year":"1986","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jpeds.2013.12.053_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1749-6632.1991.tb37787.x","article-title":"Brain tumors in tuberous sclerosis","volume":"615","author":"Shepherd","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jpeds.2013.12.053_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jnnp.66.3.370","article-title":"Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis","volume":"66","author":"Nabbout","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jpeds.2013.12.053_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/adc.2007.125880","article-title":"Sub-ependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study","volume":"93","author":"O'Callaghan","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2013.12.053_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1749-6632.1991.tb37786.x","article-title":"Mortality in the Mayo Clinic Tuberous Sclerosis Complex Study","volume":"615","author":"Shepherd","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jpeds.2013.12.053_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1520\/JFS2002134","article-title":"Mechanisms of unexpected death in tuberous sclerosis","volume":"48","author":"Byard","year":"2003","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.jpeds.2013.12.053_bib13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","article-title":"Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype\u2013phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex","volume":"13","author":"Sancak","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jpeds.2013.12.053_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4255\/mcpharmacol.09.16","article-title":"Developing antiepileptogenic drugs for acquired epilepsy: targeting the mammalian target of rapamycin (mTOR) pathway","volume":"1","author":"Zeng","year":"2009","journal-title":"Mol Cell Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.jpeds.2013.12.053_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02438.x","article-title":"The pathophysiology of tuberous sclerosis complex","volume":"51","author":"Crino","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpeds.2013.12.053_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2013.12.053_bib17","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2013.12.053_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2013.12.053_bib19","first-page":"1238","article-title":"Tuberous Sclerosis Consensus Conference: revised clinical diagnostic criteria","volume":"23","author":"Roach","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jpeds.2013.12.053_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","article-title":"Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies","volume":"51","author":"Wong","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpeds.2013.12.053_bib21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ejpn.2013.06.002","article-title":"Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?","volume":"17","author":"Wiegand","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jpeds.2013.12.053_bib22","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1523\/JNEUROSCI.3486-09.2009","article-title":"mTOR signaling in epileptogenesis: too much of a good thing?","volume":"29","author":"Cao","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpeds.2013.12.053_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.03.021","article-title":"A pulse rapamycin therapy for infantile spasms and associated cognitive decline","volume":"43","author":"Raffo","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jpeds.2013.12.053_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1399-3046.2005.00360.x","article-title":"Replacing calcineurin inhibitors with mTOR inhibitors in children","volume":"9","author":"Sindhi","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jpeds.2013.12.053_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2003.09.003","article-title":"Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1-independent pathway","volume":"172","author":"Castro","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jpeds.2013.12.053_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2013.12.053_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","author":"Krueger","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2013.12.053_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/ern.13.48","article-title":"A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials","volume":"13","author":"Wong","year":"2013","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jpeds.2013.12.053_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11523-009-0105-1","article-title":"The toxicities of modern targeted therapies: learning from the price of progress","volume":"4","author":"Giles","year":"2009","journal-title":"Target Oncol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347613015990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347613015990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T19:52:38Z","timestamp":1538855558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347613015990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0022347613015990"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2013.12.053","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}